Quarterly report pursuant to Section 13 or 15(d)

General (Details)

v3.21.2
General (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Jun. 30, 2020
Dec. 31, 2019
Accounting Policies [Abstract]        
Recapitalization transaction, percentage 100.00%      
Risk factors, description As of June 30, 2021, the Company had a cash and cash equivalents and restricted cash balance of approximately $47,253, which management believes is sufficient to fund its operations for more than 12 months from the date of issuance of these condensed consolidated financial statements and sufficient to fund its operations necessary to continue development activities of its current proposed products.      
Cash and cash equivalents and restricted cash balance $ 47,253 $ 37,240 $ 60,230 $ 72,410